Adjunctive Dulaglutide in Relapsing-Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial
Study Overview The research presented offers insights into the use of dulaglutide as an adjunct treatment in individuals with relapsing-remitting […]
